by Alliance for Natural Health – USA
Meanwhile, the FDA won’t stop trying to eliminate brain health supplements. We think they want to clear the field for when they finally do approve a drug.
Two years ago we reported that Eli Lilly had a potential blockbuster drug for Alzheimer’s in the third and final phase of FDA trials. If it won approval, it was expected to bring in $7.6 billion in sales by 2024.
The results are in, and it’s back to the drawing board for Eli Lilly. The drug showed no statistically significant benefits in halting cognitive …read more
Read more here: Health Impact News
- Rating:
- Views:373 views
- Categories: Health
Thanks! Share it with your friends!
Tweet
Share
Pin It
LinkedIn
Google+
Reddit
Tumblr